Safety of Supplementing Axillary Brachial Plexus Blocks
Brendan T. Finucane, Fred Yilling
Abstract
Brendan T. Finucane, Fred Yilling
Abstract
The incidence of failed local anesthetic axillary blockade varies but can be as high as 20-30%. The authors propose to evaluate the safety of supplementing an axillary block with mepivacaine 30 min after the initial injection. An axillary blockade was performed on 10 healthy patients scheduled for forearm or hand surgery using a new catheter technique. Mepivacaine 1% with epinephrine (7 mg/kg) was administered initially and followed 30 min later by half the original dose (3.5 mg/kg). Plasma levels of mepivacaine were estimated at frequent intervals for 5 h after the initial injection. There were no symptoms or signs of local anesthetic toxicity, and plasma levels of mepivacaine remained below those that usually caused symptoms. In conclusion, the authors conclude that mepivacaine 1% with epinephrine (10.5 mg/kg) can be safely administered in divided doses into the axillary sheath within a 31-min period.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The incidence of failed local anesthetic axillary blockade varies but can be as high as 20-30%. The authors propose to evaluate the safety of supplementing an axillary block with mepivacaine 30 min after the initial injection. An axillary blockade was performed on 10 healthy patients scheduled for forearm or hand surgery using a new catheter technique. Mepivacaine 1% with epinephrine (7 mg/kg) was administered initially and followed 30 min later by half the original dose (3.5 mg/kg). Plasma levels of mepivacaine were estimated at frequent intervals for 5 h after the initial injection. There were no symptoms or signs of local anesthetic toxicity, and plasma levels of mepivacaine remained below those that usually caused symptoms. In conclusion, the authors conclude that mepivacaine 1% with epinephrine (10.5 mg/kg) can be safely administered in divided doses into the axillary sheath within a 31-min period.
Key concepts: Mepivacaine, Medicine, Anesthesia, Brachial plexus, Epinephrine, Local anesthetic, Blockade, Anesthetic